D05.11 Intraductal carcinoma in situ of right breast
ICD10CM code
ICD10CM
Name of the Condition
Intraductal carcinoma in situ of right breast (Ductal Carcinoma In Situ, DCIS)
Summary
Intraductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer wherein abnormal cells are found in the lining of a breast duct. It is considered the earliest form of breast cancer and is localized within the ducts of the breast tissue.
Causes
The exact cause of DCIS is not known. However, it involves genetic mutations in the DNA of breast duct cells, which lead to their uncontrolled growth.
Risk Factors
Age (most common in women over 50)
Family history of breast cancer
Personal history of breast conditions
Genetic mutations (e.g., BRCA1 and BRCA2)
Hormonal factors such as hormone replacement therapy
Lifestyle factors such as diet, physical activity, and alcohol use.
Symptoms
DCIS often does not produce noticeable symptoms.
It might be detected as a breast lump or through mammography, revealing microcalcifications.
Diagnosis
Mammogram to detect abnormalities in breast tissue.
Biopsy to examine tissue samples under a microscope.
MRI for a more detailed imaging study in certain cases.
Treatment Options
Surgery (lumpectomy or mastectomy) to remove the affected tissue.
Radiation therapy often follows surgery to destroy remaining abnormal cells.
Hormone therapy might be used, particularly if the abnormal cells have hormone receptors.
Prognosis and Follow-Up
The prognosis for DCIS is generally excellent given its non-invasive nature and high treatability.
Regular follow-up mammograms and check-ups are crucial to monitor for recurrence.
Complications
Recurrence in the same breast or development of invasive breast cancer if not adequately treated.
Lifestyle & Prevention
Maintain a healthy weight and balanced diet.
Regular physical activity.
Limit alcohol consumption.
Discuss screening options and frequency with healthcare providers.
When to Seek Professional Help
Any noticeable changes in the breast such as lumps or persistent mammographic abnormalities should be evaluated by a healthcare professional.